Manufacturers of surgical mesh products must stop selling and distributing their products in the United States immediately, the US Food and Drug Administration ordered Tuesday. The FDA said it “has ...

The U.S. Food and Drug Administration has issued an update on serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse (POP), indicating these ...

After issuing safety warnings, the FDA may revoke its approvals of transvaginal mesh devices made by Boston Scientific and Johnson & Johnson, according to a Mass Device report. The devices, used to ...

The U.S. Food and Drug Administration has issued a proposed rule to reclassify surgical mesh for transvaginal repair of pelvic organ prolapse as a Class III “high-risk device.” The mesh is currently ...